Common Contracts

4 similar Support Agreement contracts by Carisma Therapeutics Inc., Ocugen, Inc.

SUPPORT AGREEMENT
Support Agreement • June 23rd, 2025 • Ocugen, Inc. • Biological products, (no disgnostic substances) • Delaware

This Support Agreement (this “Agreement”), is made as of [●], 2025, by and among Orthocellix, Inc., a Delaware corporation (the “Company”), Ocugen, inc., a Delaware corporation (the “Guarantor”), Carisma Therapeutics Inc., a Delaware corporation (“Parent”), and the Person set forth on Schedule A hereto (the “Stockholder”).

SUPPORT AGREEMENT
Support Agreement • June 23rd, 2025 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Delaware

This Support Agreement (this “Agreement”), is made as of [●], 2025, by and among OrthoCellix, Inc., a Delaware corporation (the “Company”), Ocugen Inc., a Delaware corporation (the “Guarantor”), Carisma Therapeutics, Inc., a Delaware corporation (“Parent”), and the Person set forth on Schedule A hereto (the “Stockholder”).

SUPPORT AGREEMENT
Support Agreement • June 23rd, 2025 • Carisma Therapeutics Inc. • Pharmaceutical preparations • Delaware

This Support Agreement (this “Agreement”), is made as of [●], 2025, by and among Orthocellix, Inc., a Delaware corporation (the “Company”), Ocugen, inc., a Delaware corporation (the “Guarantor”), Carisma Therapeutics Inc., a Delaware corporation (“Parent”), and the Person set forth on Schedule A hereto (the “Stockholder”).

SUPPORT AGREEMENT
Support Agreement • June 23rd, 2025 • Ocugen, Inc. • Biological products, (no disgnostic substances) • Delaware

This Support Agreement (this “Agreement”), is made as of [●], 2025, by and among OrthoCellix, Inc., a Delaware corporation (the “Company”), Ocugen Inc., a Delaware corporation (the “Guarantor”), Carisma Therapeutics, Inc., a Delaware corporation (“Parent”), and the Person set forth on Schedule A hereto (the “Stockholder”).